1887

Abstract

The aim of the present study was to gain an insight into the role of virulence determinants and biofilm production in bacteraemia of urinary tract origin. For this purpose 105 isolates from patients with bacteraemia of urinary tract origin, isolated at the Institute of Microbiology and Immunology, University of Ljubljana, Slovenia, were investigated. A total of 88 strains (84 %) were isolated from immunocompromised patients and 17 (16 %) from non-immunocompromised patients. The prevalence of virulence factor (VF)-encoding genes and associations with phylogenetic background, antibiotic resistance, biofilm production and patient status were analysed by PCR and bioassay. Biofilm was produced by 55 (53 %) of the strains. No combination of VFs was highly associated with biofilm production. Of the tested VF-encoding genes, , C and the adhesin-encoding were significantly more prevalent among strains from non-immunocompromised patients. Our results indicate that the uropathogenic specific protein (USP) may be, as judged by predominance and associations of the gene, an important VF contributing significantly to bacteraemia of urinary tract origin.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.2008/002543-0
2008-11-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/11/1329.html?itemId=/content/journal/jmm/10.1099/jmm.0.2008/002543-0&mimeType=html&fmt=ahah

References

  1. Ambrožič J., Ostroveršnik A., Starčič M., Kuhar I., Grabnar M., Žgur-Bertok D. 1998; Escherichia coli ColV plasmid pRK100: genetic organization, stability and conjugal transfer. Microbiology 144:343–352 [CrossRef]
    [Google Scholar]
  2. Bingen-Bidois M., Clermont O., Bonacorsi S., Terki M., Brahimi N., Loukil C., Barraud D., Bingen E. 2002; Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 70:3216–3226 [CrossRef]
    [Google Scholar]
  3. Clermont O., Bonacorsi S., Bingen E. 2000; Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555–4558 [CrossRef]
    [Google Scholar]
  4. CLSI 2007 Performance Standards for Antimicrobial Susceptibility Testing , 17th informational supplement M100S171–177 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  5. Costerton J. W., Stewart P. S., Greenberg E. P. 1999; Bacterial biofilms – a common cause of persistent infections. Science 284:1318–1322 [CrossRef]
    [Google Scholar]
  6. Drews S. J., Poutanen S. M., Mazzulli T., McGreer A. J., Sarabia A., Pong-Porter S., Rzayev Y., Willey B., Green K., Low D. F. 2005; Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J Clin Microbiol 43:4218–4220 [CrossRef]
    [Google Scholar]
  7. Duguid J. P., Clegg S., Wilson M. I. 1979; The fimbrial and non-fimbrial haemagglutinins of Escherichia coli . J Med Microbiol 12:213–227 [CrossRef]
    [Google Scholar]
  8. Hanna A., Berg M., Stout V., Razatos A. 2003; Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli . Appl Environ Microbiol 69:4474–4481 [CrossRef]
    [Google Scholar]
  9. Herzer P. J., Inouye S., Inouye M., Whittam T. S. 1990; Phylogenetic distribution of branched RNA-linked multi-copy single-stranded DNA among natural isolates of Escherichia coli . J Bacteriol 172:6175–6181
    [Google Scholar]
  10. Horcajada J. P., Soto S., Gajewski A., Smithson A., Jiménez de Anta M. T., Mensa J., Vila J., Johnson J. R. 2005; Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 43:2962–2964 [CrossRef]
    [Google Scholar]
  11. Houdouin V., Bonacorsi S., Bidet P., Bingen-Bidois M., Barraud D., Bingen E. 2006; Phylogenetic background and carriage of pathogenicity island-domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J Antimicrob Chemother 58:748–751 [CrossRef]
    [Google Scholar]
  12. Hultgren S. J., Porter T. N., Schaeffer A. J., Duncan J. L. 1985; Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli . Infect Immun 50:370–377
    [Google Scholar]
  13. Izumi E., Domingues Pires P., Bittencourt de Marques E., Suzart S. 2005; Hemagglutinating and hemolytic activities of Enterococcus faecalis strains isolated from different human clinical sources. Res Microbiol 156:583–587 [CrossRef]
    [Google Scholar]
  14. Johnson J. R. 1991; Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4:80–128
    [Google Scholar]
  15. Johnson J. R. 1994; Pathogenesis of bacteremia during pyelonephritis. Clin Infect Dis 18:1014–1015 [CrossRef]
    [Google Scholar]
  16. Johnson J. R., Stell A. L. 2000; Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181:261–272 [CrossRef]
    [Google Scholar]
  17. Johnson J. R., Mosely S. L., Roberts P. L., Stamm W. E. 1988; Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 56:405–412
    [Google Scholar]
  18. Johnson J. R., Brown J. J., Maslow J. N. 1998; Clonal distribution of the three alleles of the gal( α 1–4)gal-specific adhesin gene papG among Escherichia coli strains from patients with bacteremia. J Infect Dis 177:651–661 [CrossRef]
    [Google Scholar]
  19. Johnson J. R., Russo T. A., Tarr P. I., Carlino U., Bilge S. S., Vary J. C. Jr, Stell A. L. 2000; Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroNE.coli , among Escherichia coli isolates from patients with urosepsis. Infect Immun 68:3040–3047 [CrossRef]
    [Google Scholar]
  20. Johnson J. R., Kuskowski M. A., O'Bryan T. T., Maslow J. N. 2002; Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J Infect Dis 185:1439–1447 [CrossRef]
    [Google Scholar]
  21. Johnson J. R., Kuskowski M. A., Gajewski A., Soto S., Horcajada J. P., Jimenez de Anta M. T., Vila J. 2005; Extended virulence genotypes and phyelonephritis or prostatitis. J Infect Dis 191:46–50 [CrossRef]
    [Google Scholar]
  22. Johnson J. R., Clermont O., Menard M., Kuskowski M. A., Picard B., Denamur E. 2006; Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group and ecological source. J Infect Dis 194:1141–1150 [CrossRef]
    [Google Scholar]
  23. Kanamaru S., Kurazono H., Ishitova S., Terai A., Habuchi T., Nakano M., Ogawa O., Yamamoto S. 2003; Distribution and genetic association of putative uropathogenic virulence factors iroN , iha , kpsMT , ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol 170:2490–2493 [CrossRef]
    [Google Scholar]
  24. Kanamaru S., Kurazono H., Nakano M., Terai A., Ogawa O., Yamamoto S. 2006; Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic-specific protein: comparison with phylogenetic groups. Int J Urol 13:754–760 [CrossRef]
    [Google Scholar]
  25. Le Bouguenec C., Archambaud M., Labigne A. 1992; Rapid and specific detection of pap , afa , and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 30:1189–1193
    [Google Scholar]
  26. Martínez J. A., Soto S., Fabrega A., Almela M., Mensa J., Soriano A., Marco F., Jimenez de Anta M. T., Vila J. 2006; Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia. J Clin Microbiol 44:1468–1474 [CrossRef]
    [Google Scholar]
  27. Maslow J. N., Mulligan M. E., Adams K. S., Justis J. C., Arbeit R. D. 1993; Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia. Clin Infect Dis 17:89–97 [CrossRef]
    [Google Scholar]
  28. Maslow J. N., Whittam T. S., Gilks C. F., Wilson R. A., Mulligan M. E., Adams K. S., Arbeit R. D. 1995; Clonal relationships among bloodstream isolates of Escherichia coli . Infect Immun 63:2409–2417
    [Google Scholar]
  29. McBean M., Rajamani S. 2001; Increasing rates of hospitalization due to septicemia in the US elderly population, 1986–1997. J Infect Dis 183:596–603 [CrossRef]
    [Google Scholar]
  30. Moreno E., Planells I., Prats A. M., Moreno G., Andreu A. 2005; Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia. Diagn Microbiol Infect Dis 53:93–99 [CrossRef]
    [Google Scholar]
  31. Nakano M., Yamamoto S., Terai A., Ogawa O., Makino S., Hayashi H., Nair G. B., Kurazono H. 2001; Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP protein. FEMS Microbiol Lett 205:71–76 [CrossRef]
    [Google Scholar]
  32. Nowrouzian F., Adlerberth I., Wold A. E. 2001; P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli . Epidemiol Infect 126:11–18
    [Google Scholar]
  33. O'Toole G. A., Kolter R. 1998; Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28:449–461 [CrossRef]
    [Google Scholar]
  34. Otto G., Magnusson M., Svensson M., Braconier J., Svanborg C. 2001; pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection. Clin Infect Dis 32:1523–1531 [CrossRef]
    [Google Scholar]
  35. Parret A. H., De Mot R. 2002; Escherichia coli 's uropathogenic-specific protein: a bacteriocin promoting infectivity?. Microbiology 148:1604–1606
    [Google Scholar]
  36. Piatti G., Mannini A., Balistreri M., Schito A. M. 2008; Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 46:480–487 [CrossRef]
    [Google Scholar]
  37. Picard B., Garcia J., Gouriou S., Duriez P., Brahimi N., Bingen E., Elion J., Denamur E. 1999; The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67:546–553
    [Google Scholar]
  38. Prüss B. M., Besemann C., Denton A., Wolfe A. J. 2006; A complex transcription network controls the early stages of biofilm development by Escherichia coli . J Bacteriol 188:3731–3739 [CrossRef]
    [Google Scholar]
  39. Ronald A. 2002; The etiology of urinary tract infection: tradition and emerging pathogens. Am J Med 113 (Suppl. 1A):14S–19S [CrossRef]
    [Google Scholar]
  40. Ruiz J., Simon K., Horcajada J. P., Velasco M., Barranco M., Roig G., Moreno-Martínez A., Martínez J. A., Jiménez de Anta T. other authors 2002; Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 40:4445–4449 [CrossRef]
    [Google Scholar]
  41. Salit I. E., Gotschlich E. C. 1977; Hemagglutination by purified type I Escherichia coli pili. J Exp Med 146:1169–1180 [CrossRef]
    [Google Scholar]
  42. Soto S. M., Smithson A., Martinez J. A., Horcajada J. P., Mensa J., Vila J. 2007; Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol 177:365–368 [CrossRef]
    [Google Scholar]
  43. Stamm W. E., Hooton T. M. 1993; Management of urinary tract infections in adults. N Engl J Med 329:1328–1334 [CrossRef]
    [Google Scholar]
  44. Usein C.-R., Damain M., Tatu-Chitoiu D., Capusa C., Fagaras R., Tudorache D., Nica M., Le Bouguénec C. 2001; Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Med 5:303–310 [CrossRef]
    [Google Scholar]
  45. Vieira H. L., Freire P., Arraiano C. M. 2004; Effect of Escherichia coli morphogene bolA on biofilms. Appl Environ Microbiol 70:5682–5684 [CrossRef]
    [Google Scholar]
  46. Vila J., Simon K., Ruiz J., Horcajada J. P., Velasco M., Barranco M., Moreno A., Mensa J. 2002; Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J Infect Dis 186:1039–1042 [CrossRef]
    [Google Scholar]
  47. Yamamoto S., Terai A., Yuri K., Kurazono H., Takeda Y., Yoshida O. 1995; Detection of virulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 12:85–90 [CrossRef]
    [Google Scholar]
  48. Yamamoto S., Nakano M., Terai A., Yuri K., Nakata K., Nair G. B., Kurazono H., Ogawa O. 2001; The presence of the virulence island containing the usp gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model. J Urol 165:1347–1351 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.2008/002543-0
Loading
/content/journal/jmm/10.1099/jmm.0.2008/002543-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error